LivaNova initiates process with U.S. Centers for Medicare and Medicaid Services

LivaNova (LIVN) announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services to seek reconsideration of national Medicare coverage for VNS Therapy in unipolar patients with treatment-resistant depression. The first step in the process for making a National Coverage Determination is the submission of a draft formal request for CMS reconsideration.